Zoetis (ZTS) EBT Margin (2012 - 2026)
Zoetis' (ZTS) quarterly EBT Margin came in at 33.51% in Q1 2026, down 166.0% year-on-year from 50.77% in Q1 2025, and up 5.11% on a QoQ basis from 31.88% in Q4 2025.
Zoetis (ZTS) EBT Margin (2012 - 2026) Analysis & Trends
Zoetis (ZTS) has 15 years of EBT Margin data on file, last reported at 33.51% in Q1 2026.
- On a quarterly basis, EBT Margin fell 166.0% year-over-year to 33.51% in Q1 2026; TTM through Mar 2026 was 34.79%, a 69.0% increase from a year earlier, with the FY2025 full-year figure at 35.49%, up 164.0% from the prior year.
- EBT Margin for Q1 2026 stood at 33.51%, up from 31.88% in the prior quarter.
- Over the last five years, EBT Margin for ZTS reached as high as 40.0% in Q2 2023 and fell as low as 29.02% in Q4 2022.
- Historically, EBT Margin has averaged 34.04% across 5 years, with a median of 33.51% in 2026.
- Across the five-year window, EBT Margin soared 735 bps in 2023 and sank 696 bps in 2024, its largest moves.
- Year by year, EBT Margin stood at 29.02% in 2022, then advanced by 1 bps to 29.37% in 2023, then grew by 8 bps to 31.59% in 2024, then gained by 1 bps to 31.88% in 2025, then gained by 5 bps to 33.51% in 2026.
- Per Business Quant data, the three most recent EBT Margin figures were 33.51% in Q1 2026, 31.88% in Q4 2025, and 36.96% in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn | 10.97% |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn | 33.51% |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn | -41.57% |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn | 40.73% |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn | -7.05% |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn | 30.30% |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn | 6.35% |
| 10 | Vireo Growth | 10.53 Bn | 10.38 Bn | 59.30 Mn | -3.95% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 33.51% |
| Dec 31, 2025 | 31.88% |
| Sep 30, 2025 | 36.96% |
| Jun 30, 2025 | 36.67% |
| Mar 31, 2025 | 35.17% |
| Dec 31, 2024 | 31.59% |
| Sep 30, 2024 | 36.60% |
| Jun 30, 2024 | 33.04% |
| Mar 31, 2024 | 34.11% |
| Dec 31, 2023 | 29.37% |
| Sep 30, 2023 | 33.33% |
| Jun 30, 2023 | 40.00% |
| Mar 31, 2023 | 34.85% |
| Dec 31, 2022 | 29.02% |
| Sep 30, 2022 | 33.32% |
| Jun 30, 2022 | 32.65% |
| Mar 31, 2022 | 36.61% |
| Dec 31, 2021 | 25.72% |
| Sep 30, 2021 | 33.12% |
| Jun 30, 2021 | 32.65% |